DrugAlpha 创新药投研
Server Details
Company/drug identification and published biopharma catalysts. DrugAlpha OAuth account required.
Glama couldn't complete the latest health check. If this server requires authentication, missing or expired test credentials may be the cause. A test profile lets Glama authenticate for health checks and discover tools; it is separate from your personal connections.
If you are the author, claim ownership, then add or update a test profile under Admin → Test Profile.
- Status
- Unhealthy
- OAuth
- Not checked
- Last Tested
- Transport
- Streamable HTTP
- URL
- Repository
- max-nobug/drugalpha-mcp
- GitHub Stars
- 0
Related MCP Connectors
Broad, OAuth-protected provider and financial-domain API tools for research agents.
Evidence-aware supply-chain research. Authentication required: OAuth or a client-stored API key.
Regulatory Catalysts MCP — high-value biotech regulatory calendar events (keyless).
Pharma Intel MCP — Compound tools that chain ClinicalTrials.gov,
Related MCP Servers
- AlicenseAqualityDmaintenanceEnables biopharma catalyst research by aggregating signals from ClinicalTrials.gov, PubMed, SEC EDGAR, openFDA, and Yahoo Finance, with a single tool to audit a ticker/drug combination and return a forensic verdict.1027 npm5ISC
- AlicenseAqualityAmaintenanceProvides read-only tools to retrieve source-linked catalyst evidence dossiers for public-company tickers, including deterministic catalyst scores and paged source records.227 PyPIMIT
- AlicenseNot gradedqualityBmaintenanceProvides keyless access to HKEX and CNINFO exchange disclosure feeds, enabling search and retrieval of Chinese biotech licensing deals and Hong Kong/STAR IPO financing filings.279 npmMIT
- AlicenseNot gradedqualityBmaintenanceEnables querying China-to-Western biotech licensing deals, NMPA drug approvals and policy updates, and CSRC securities penalties, all extracted from public SEC, HKEX, and government filings without an API key.254 npmMIT
Glama MCP Gateway
Add one secure layer between your agents and this server.